BWX Technologies (BWXT) will report fiscal 2026 third-quarter results after market close. The company builds nuclear reactors and components for U.S. Navy submarines and aircraft carriers, and is the sole nuclear fuel provider to the Navy, while also serving the commercial nuclear energy market. Although the shares are down 40% over six months, the article says the drop is not due to weak operations: management raised its fiscal 2026 revenue forecast to about $3.8 billion, and backlog stood at $8.4 billion as of June 30. The stock fell from an April 52-week high of $241.82 to a 52-week low of $123.05, mainly amid a broader sell-off in defense stocks over midterm election concerns and in nuclear stocks over worries about AI data center spending. Management expects nearly 55% of second-half earnings to come in the fourth quarter and targets $5.5 billion to $6 billion in revenue by 2030, and the article says the long-term thesis has not changed.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on Yahoo Finance ↗
Keywords
Open a keyword to see other news on the same topic.
Related news
- Centrus vs. BWX Technologies: Which Nuclear Supply Chain Stock Is the Better Buy After the Sell-Off?
Centrus Energy (LEU) and BWX Technologies (BWXT) soared with the nuclear revival last year but are down 54% and 22%, respectively, in 2026. The Bank of America Institute projects U.S. electricity demand to grow 5 times faster over the next decade than it did over the last, driven by AI data centers, EVs and reshoring. Centrus is shifting from sourcing fuel to producing enriched uranium domestically, with fuel supply deals announced with Oklo, X-energy, Radiant and Antares, though its capital-intensive build-out will weigh on earnings for the next couple of years. BWXT is the only manufacturer of naval nuclear reactors and fuel for the U.S. Navy, secured $1.4 billion in Naval Nuclear Propulsion Program contracts in May 2026, and also fabricates the reactor pressure vessel for GE Vernova's BWRX-300 SMR. The article suggests Centrus suits investors comfortable with volatility for nuclear build-out upside, while BWXT suits those seeking stability.
- The U.S. Army Is Spending $2.2 Billion on Micro Nuclear Reactors. This Stock Could Benefit.
On Aug. 26, the U.S. Army announced $2.2 billion in funding for several companies to own, build and operate nuclear microreactors for military installations, under its Janus Program launched in 2025. The goal is to supply safe, reliable power to the military through more than 20 microreactors, which are factory-assembled modular designs that can be built faster and at lower cost than large plants. BWX Technologies (BWXT) was selected as one of the vendors, given its long history of building reactors for the U.S. Navy. BWXT shares rose about 136% over five years but fell about 40% over the past six months, and the company recently raised its 2026 guidance for revenue, adjusted EBITDA, non-GAAP EPS and free cash flow. The article notes BWXT has a proven record of deploying its technology and earning profits, unlike some SMR companies without earnings.
- Vistra Slides 17% in Three Months Despite a $4.2 Billion Nuclear Loan Offer
Vistra (VST) closed at $140 on October 23, down 16.9% over three months and 31% below its $203.66 high, even after the Energy Department's October 5 conditional commitment of up to $4.2 billion in loans for its nuclear fleet. The loans would fund uprates and modernization at Beaver Valley, Davis-Besse and Perry, preserving nearly 4 GW of existing output and adding 433 MW of new capacity, subject to technical, legal, environmental and financial conditions. Vistra has 20-year PPAs with Meta for 2,609 MW, including the 433 MW of planned uprates, and a roughly $4 billion Cogentrix deal adds 10 modern plants with about 5,500 MW, expected to close in mid-to-late 2026. Q2 revenue fell 5.5% to $4.02 billion, well below the $5.57 billion consensus, though adjusted EBITDA rose more than 30%; management said power prices remain too low for new-build projects to earn adequate returns, and 2026 adjusted EBITDA guidance of $6.8–7.6 billion was held. Retail president Scott Hudson sold more than $10 million of shares, and the author notes Vistra trades at 13.8x forward earnings versus 20.5x for Constellation, arguing the discount looks too wide if guidance holds, though he wants the loan finalized
- Got $1,000? This Nuclear Fuel Stock Is the Pick-and-Shovel Play I'd Buy Right Now.
Nuclear energy stocks have fallen this year, with the Global X Uranium ETF (URA) down around 15% year to date as the sector appears to have overheated on enthusiasm over nuclear power deals for AI data centers. The article highlights Centrus Energy (LEU), the lone publicly traded proven U.S. uranium enricher, which operates the only NRC-licensed U.S. facility capable of producing HALEU and finalized a $900 million DOE order in July. Second-quarter revenue rose 13.9% to $176.1 million, full-year revenue is estimated at $450–500 million versus $448.7 million in 2025, and the company holds a $4.5 billion backlog extending to 2040. Adjusted net income grew 12% to $38.7 million, while adjusted EPS was flat at $1.95. The author argues the more than 52% year-to-date decline, with shares trading at about 33 times forward earnings, reflects sector concerns more than the company's sound financial health.
- Should You Buy Vistra After an 11% 1-Day Jump on a $4.2 Billion DOE Loan? The Catch Most Investors Are Missing.
On Oct. 5, 2026, the U.S. Department of Energy announced a conditional loan commitment of up to $4.2 billion to modernize three Vistra nuclear plants in Ohio and Pennsylvania, aiming to add 433 megawatts of capacity and extend their operating lives by 20 years. Vistra shares jumped 11% in a single day on the news. Ongoing Operations Adjusted EBITDA for Q2 2026 rose more than 30% year over year to around $1.8 billion, driven mainly by higher energy and capacity prices and acquired plants. The article stresses that the DOE package is financing, not a grant, so Vistra must meet technical, legal, environmental and financial requirements and repay the loan, and delays or cost overruns could push back payoff. The stock trades at a P/E of about 26, and 18 analysts rate it a Strong Buy.
- MPLX Reports Earnings on Nov. 3, 2026. Here's What Investors Should Be Watching.
MPLX will report third-quarter results on Tuesday, Nov. 3, after management said the third quarter should be stronger than the second, and the fourth stronger still. The MLP spent $5.5 billion on growth projects and acquisitions last year and plans $2.9 billion in growth capex in 2026, aiming for mid-single-digit adjusted EBITDA growth. First-half adjusted EBITDA reached $3.5 billion, up less than 2% year over year, so the second half must accelerate. The article estimates third-quarter adjusted EBITDA near $1.85 billion, versus nearly $1.8 billion in the second quarter. The board declared a third-quarter distribution of $1.2111 per unit, up 12.5% year over year, making distribution coverage (1.3x at the end of the second quarter) and leverage (3.7x, versus a 4.0x target) key metrics to watch.
Related markets
Latest news
- Learn Why The Bull Case For JPMorgan Chase Stock Could Change Following Earnings Miss
JPMorgan Chase reported third-quarter earnings below expectations for the first time since 2023, while raising its 2026 net interest income outlook to about US$106.2 billion. The bank is cutting share buybacks and raising its dividend, directing capital toward technology, AI and franchise investment and accepting higher noninterest expenses rather than maximizing near-term payouts. It is also issuing multiple callable senior unsecured notes maturing between 2031 and 2056, with coupons mostly in the 5.5% to 6.7% range, signaling a focus on balance sheet flexibility and long-dated funding. The article notes that a weaker credit or capital markets environment combined with elevated spending could squeeze margins and returns. Consensus figures project revenue of US$227.1 billion and earnings of US$68.8 billion by 2029, based on an assumed 6.8% annual revenue growth rate, an increase of about US$5.2 billion from current earnings of US$63.6 billion.
- Barclays Says a SpaceX Merger Is Now "a Key Part" of the Tesla Bull Case. Here's Who Actually Wins if It Happens -- and Who Pays.
On Space Exploration Technologies' (SPCX) third-quarter conference call, CEO Elon Musk said he thought a merger with Tesla was a good idea, and the two companies have each formed a special committee to explore a combination. Barclays says such a deal would likely be funded largely or entirely through stock, and Tesla shareholders could benefit given SpaceX's market capitalization of roughly $2 trillion compared with roughly $1.55 trillion for Tesla. Barclays upgraded Tesla from equal weight to overweight and raised its one-year price target from $370 to $450 per share, a level that matches its expected all-stock buyout value, a premium of roughly 20% over the current price, or about 3.1 SpaceX shares per Tesla share. The deal would need a 50% affirmative vote from Tesla shareholders, with investors who do not vote counted as "no" votes, and Musk controls about 20% of voting power but would still likely need meaningful retail investor support. The article also notes that heavy dilution from new SpaceX share issuance to fund a deal makes the post-deal outlook for SpaceX stock harder to predict.
- Centerra Gold Inc (CGAU) (Q3 2026) Earnings Call Highlights: Record Buybacks, Lower Mount ...
Centerra Gold reported third-quarter adjusted net earnings of $72 million, or $0.37 per share, with operating cash flow of $143 million and free cash flow of $17 million. The company bought back a record $53 million of shares in the quarter, bringing year-to-date repurchases to $125 million, and declared a quarterly dividend of $0.07 per share. Mount Milligan's third-quarter all-in sustaining cost on a byproduct basis was $985 per ounce, and full-year guidance was lowered to $1,100–$1,200 per ounce from $1,200–$1,300, supported by copper by-product credits. The Thompson Creek restart is about 75% complete with first molybdenum production expected in mid-2027, though molybdenum prices cannot be hedged and Mount Milligan costs are tracking about 5% above budget. Cash fell roughly $50 million in the quarter, and the company plans to hold only $100–$200 million in cash, with total liquidity of $998 million.
- Prediction: Nvidia Stock Is Going to Soar After Nov. 17
Nvidia's market capitalization tops $5 trillion, and its stock is up nearly 15% in 2026. Revenue in the fiscal 2027 second quarter reached $96.2 billion, up 106% year over year, with a 75% non-GAAP gross margin. The company forecasts about $108 billion in third-quarter revenue, while analysts expect about $109 billion. CEO Jensen Huang sees global AI infrastructure spending reaching $3 trillion to $4 trillion by 2030, and the Vera Rubin platform could generate $40 billion per gigawatt, 60% more than Blackwell. Nvidia trades at about 23 times forward earnings versus 18.6 for the S&P 500, which the author considers reasonable given its growth; the company reports on Nov. 17.
- Intuitive Surgical Stock Just Fell Despite a 22% Revenue Jump. Here's What Investors Are Missing.
Intuitive Surgical (ISRG) shares fell after the company reported earnings, despite a 22% jump in revenue. The article argues the real revenue driver is not da Vinci robot sales, which account for roughly 25% of revenue, but instruments, accessories, and services. Although Medtronic and Johnson & Johnson have entered surgical robotics, Intuitive sold more da Vinci systems in Q3 2026 than in Q3 2025, and procedures rose 15% while installed systems grew 12% year over year. With more than 12,000 installed systems generating recurring income, the article says the company still has room to grow as surgical robotics is far from saturation.
- Energy Transfer's Next Earnings Report Could Send the Stock Higher
Energy Transfer (ET) reports third-quarter earnings this week on Tuesday, after a strong run that has lifted its unit price nearly 27% this year. In Q2, adjusted EBITDA rose 31% to nearly $5.1 billion and distributable cash flow rose 32% to $2.6 billion, and the company raised its full-year adjusted EBITDA outlook for the second time this year, to $18.8 billion to $19.1 billion. Growth projects include the $2.7 billion Hugh Brinson Pipeline in Texas for data center and AI demand, an expansion of the Transwestern Pipeline of up to $5.6 billion, NGL export expansion, and the $2.6 billion Vaquero Midstream acquisition. Risks include growth capital spending now planned at $5.6 billion to $5.9 billion, up from an initial $5 billion to $5.5 billion, along with construction and volume risks. The 6.5%-yielding pipeline partnership has posted 20 consecutive quarterly distribution increases and expects to grow its payout by 3% to 5% each year.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.